Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856238) titled 'Long-Term Effectiveness and Safety of Sacral Neuromodulation With InterStim for Lower Urinary Tract Dysfunction' on Sept. 28.
Study Type: Observational
Primary Sponsor: Fundación Santa Fe de Bogota
Condition:
Overactive Bladder (OAB)
Urgency Urinary Incontinence
Non-obstructive Urinary Retention
Non-obstructive Acontractile Detrusor
Intervention:
Device: InterStim™ Sacral Neuromodulation System II - X
Recruitment Status: Not recruiting
Date of First Enrollment: December 1, 2026
Target Sample Size: 1700
Countries of Recruitment:
Colombia
To know more, visit https://clinicaltrials.gov/study/NCT078...